Type 2 diabetes mellitus, pandemic in 21st century
- PMID: 23393670
- DOI: 10.1007/978-1-4614-5441-0_6
Type 2 diabetes mellitus, pandemic in 21st century
Abstract
In the second half of the 20th century it became obvious that a relentless increase in Type 2 diabetes mellitus (T2DM), affecting the economically affluent countries, is gradually afflicting also the developing world. This chapter shows the threat that the T2DM epidemic represents to mankind, with the astonishing recent discoveries on the role of obesity and of body fat in this metabolic disorder. Presently, the highest prevalence of T2DM is in Saudi Arabia. T2DM is very high in over 10% of adults in the USA, Switzerland and Austria. Prevalence is low in Norway, China and in Iceland. Predictions of epidemiologists for the first third of the 21st century claim up to 2.5 times increase in the prevalence of T2DM in the Middle East, Sub-Saharan Africa, India, rest of Asia and in the Latin America. In China the number of patients with T2DM will double in 2030. In the economically advanced countries the increase will be about 50% in 2030. Increasing urbanization, aging populations, obesity and falling levels of physical activity are all contributing to the rise of T2DM worldwide. The main cause of T2DM pandemic is growing prevalence of obesity in Europe and USA. In the North America and European Union countries obesity is considered to be responsible for up to 70-90% of T2DM in adult population. The precise mechanism by which obesity leads to insulin resistance and to T2DM is not completely known but it may be related to several biochemical factors such as abnormalities in free fatty acids, adipokines, leptin and other substances.
Similar articles
-
Diabetes type 2 pandemic in 21st century.Bratisl Lek Listy. 2010;111(3):134-7. Bratisl Lek Listy. 2010. PMID: 20437822
-
Global prevalence and future of diabetes mellitus.Adv Exp Med Biol. 2012;771:35-41. doi: 10.1007/978-1-4614-5441-0_5. Adv Exp Med Biol. 2012. PMID: 23393669
-
Obesity, insulin resistance and diabetes--a worldwide epidemic.Br J Nutr. 2000 Mar;83 Suppl 1:S5-8. doi: 10.1017/s000711450000088x. Br J Nutr. 2000. PMID: 10889785 Review.
-
Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach.Diabetes Res Clin Pract. 2018 Mar;137:100-108. doi: 10.1016/j.diabres.2017.11.015. Epub 2017 Nov 22. Diabetes Res Clin Pract. 2018. PMID: 29175341
-
Type 2 diabetes mellitus and obesity in sub-Saharan Africa.Diabetes Metab Res Rev. 2010 Sep;26(6):433-45. doi: 10.1002/dmrr.1106. Diabetes Metab Res Rev. 2010. PMID: 20641142 Review.
Cited by
-
Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.J Diabetes Res. 2015;2015:970375. doi: 10.1155/2015/970375. Epub 2015 Apr 2. J Diabetes Res. 2015. PMID: 25922847 Free PMC article. Review.
-
Adherence to Two Methods of Education and Metabolic Control in Type 2 Diabetics.Ethiop J Health Sci. 2015 Apr;25(2):163-70. doi: 10.4314/ejhs.v25i2.9. Ethiop J Health Sci. 2015. PMID: 26124624 Free PMC article.
-
Efficacy and cost-effectiveness of a web-based intervention with mobile phone support to treat depressive symptoms in adults with diabetes mellitus type 1 and type 2: design of a randomised controlled trial.BMC Psychiatry. 2013 Nov 15;13:306. doi: 10.1186/1471-244X-13-306. BMC Psychiatry. 2013. PMID: 24238346 Free PMC article. Clinical Trial.
-
Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice.Int J Mol Sci. 2022 Aug 7;23(15):8783. doi: 10.3390/ijms23158783. Int J Mol Sci. 2022. PMID: 35955920 Free PMC article.
-
Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?Rev Diabet Stud. 2013 Summer-Fall;10(2-3):171-90. doi: 10.1900/RDS.2013.10.171. Epub 2013 Aug 10. Rev Diabet Stud. 2013. PMID: 24380091 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical